Facebook
Twitter
LinkedIn
Forward
Review Course for the 2024 ABOM Exam
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
The 2024 Obesity Medicine Association (OMA) Annual Business Meeting hosted by Lydia Alexander, MD, MFOMA, President of the OMA.
|
Women are particularly affected by weight gain during the menopausal transition, with over 40% of menopausal women estimated to have obesity. During this session, Dr.
|
Join Dr. Jaime Almandoz and Dr. Colleen Tewksbury for a deep dive into counseling patients regarding nutrition surrounding the use of anti-obesity medications (AOMs).
|
Coming Soon: The latest 2025 edition of the SAP will be launched in early 2025.
|
Coming Soon: The latest 2025 edition of the Pediatric SAP will be launched in early 2025.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
Selecting the correct on label or off label medication to treat obesity can be confusing. The acronym RXAOM provides a framework for individualizing the selection process.
|
As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios.
|